Page last updated: 2024-10-21

5-iodo-2-(oxaloamino)benzoic acid and Diabetes Mellitus, Type 2

5-iodo-2-(oxaloamino)benzoic acid has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, Y1
Zhou, M1
Tung, CH1
Ji, M1
Zhang, F1

Other Studies

1 other study available for 5-iodo-2-(oxaloamino)benzoic acid and Diabetes Mellitus, Type 2

ArticleYear
Studies on two types of PTP1B inhibitors for the treatment of type 2 diabetes: Hologram QSAR for OBA and BBB analogues.
    Bioorganic & medicinal chemistry letters, 2010, Jun-01, Volume: 20, Issue:11

    Topics: Diabetes Mellitus, Type 2; Enzyme Inhibitors; Models, Molecular; Protein Tyrosine Phosphatase, Non-R

2010